Dr. Max C. Miranda, MD

Dr. Miranda practices at Aspirus St. Luke's Hospital in Duluth, Minnesota, part of Aspirus.

Dr. Miranda's NPI, 1225259567, was assigned on May 2, 2007. Dr. Miranda graduated from University of Hawaii John A. Burns School of Medicine in 2004. Dr. Miranda holds Minnesota license 53106.

Dr. Miranda's primary practice is Aspirus St. Luke's Hospital, at 915 East 1st Street, Duluth, MN 55805 in St. Louis County. The practice phone is (218) 249-5555.

Dr. Miranda's primary practice is Aspirus St. Luke's Hospital in Duluth, Minnesota, part of Aspirus. Dr. Miranda is also affiliated with Community Memorial Hospital. The medical group on file is Aspirus St. Luke's Hospital. Dmand AI also links Dr. Miranda to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miranda practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Miranda's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Miranda is licensed in Minnesota.

CMS data shows 440 Medicare services from Dr. Miranda across 12 procedure codes in 2024, for 284 Medicare patients. Medicare paid $42,810 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 284 Medicare patients who saw Dr. Miranda in 2024. The largest group is 65 to 74, with 154 patients. 70% of them have high blood pressure, and 68% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Miranda's median patient age at 71, with 56% women.

In 2024, Dr. Miranda wrote 2,012 Medicare Part D claims for 640 patients. 87% of them were for generic drugs. CMS names the drug for 1,886 of them, across 25 drugs with 11 or more claims each, at $860,476 in total drug cost. In 2023, CMS named 1,662 claims across 24 drugs.

Dr. Miranda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 210 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Miranda, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Miranda.

CMS Open Payments shows 29 general payments to Dr. Miranda from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $85.

Dr. Miranda graduated from University of Hawaii John A. Burns School of Medicine in 2004.